Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report
Haa-Na Song, Min Gyu Kang, Jeong Rang Park, Jin-Yong Hwang, Jung Hun Kang, Won Seop Lee, Gyeong-Won Lee
Cancer Res Treat. 2018;50(4):1458-1461.   Published online 2018 Jan 22     DOI: https://doi.org/10.4143/crt.2017.529
Citations to this article as recorded by Crossref logo
Pembrolizumab and radiation therapy for multifocal myxofibrosarcoma of the scalp: a case report
Christopher Ryan Grant, Zhaohui Arter, Janellen Smith, Steven N. Seyedin, Mahra Nourbakhsh, Bonnie Lee, Andrew Creadore, Nataliya Mar
Therapeutic Advances in Medical Oncology.2024;[Epub]     CrossRef
Current Landscape of Immunotherapy for Advanced Sarcoma
Víctor Albarrán, María Luisa Villamayor, Javier Pozas, Jesús Chamorro, Diana Isabel Rosero, María San Román, Patricia Guerrero, Patricia Pérez de Aguado, Juan Carlos Calvo, Coral García de Quevedo, Carlos González, María Ángeles Vaz
Cancers.2023; 15(8): 2287.     CrossRef
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Enrico Lucarelli, Alessandro De Vita, Chiara Bellotti, Tommaso Frisoni, Silvia Vanni, Ania Naila Guerrieri, Micaela Pannella, Laura Mercatali, Marco Gambarotti, Serena Duchi, Giacomo Miserocchi, Margherita Maioli, Chiara Liverani, Toni Ibrahim
Cancers.2023; 15(21): 5132.     CrossRef
Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas
Vasiliki Siozopoulou, Evelien Smits, Karen Zwaenepoel, Jimmy Liu, Abraham Pouliakis, Patrick A Pauwels, Elly Marcq
Immunotherapy.2023; 15(15): 1257.     CrossRef
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study
Mauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, Ian Hirsch, Jay Wunder, Peter Ferguson, Kim Tsoi, Savtaj Brar, Rebecca Gladdy, Carol Swallow, Peter Chung, Charles Catton, Philip Wong, Geoffrey Watson, Albiruni Ryan Abdul Razak, Abha A. Gupta
Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives
Jun Nishio, Shizuhide Nakayama
Diagnostics.2023; 13(19): 3022.     CrossRef
Targeted therapies and checkpoint inhibitors in sarcoma
M Vasella, E Gousopoulos, M Guidi, G Storti, S Y Song, G Grieb, C Pauli, N Lindenblatt, P Giovanoli, B -S Kim
QJM: An International Journal of Medicine.2022; 115(12): 793.     CrossRef
Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case Series
Arielle Elkrief, Suzanne Kazandjian, Thierry Alcindor
Current Oncology.2021; 28(1): 813.     CrossRef
Remarkable response to anti-PD1 immunotherapy in refractory metastatic high-grade myxofibrosarcoma patient
Yi Luo, Li Min, Yong Zhou, Fan Tang, Minxun Lu, Hongmei Xie, Yitian Wang, Hong Duan, Wenli Zhang, Chongqi Tu
Medicine.2021; 100(12): e25262.     CrossRef
Is immunotherapy in the future of therapeutic management of sarcomas?
Ottavia Clemente, Alessandro Ottaiano, Giuseppe Di Lorenzo, Alessandra Bracigliano, Sabrina Lamia, Lucia Cannella, Antonio Pizzolorusso, Massimiliano Di Marzo, Mariachiara Santorsola, Annarosaria De Chiara, Flavio Fazioli, Salvatore Tafuto
Journal of Translational Medicine.2021;[Epub]     CrossRef
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS – GROUP). Part I
Javier Martínez-Trufero, Josefina Cruz Jurado, M.Carmen Gómez-Mateo, Daniel Bernabeu, Luis Javier Floría, Javier Lavernia, Ana Sebio, Xavier García del Muro, Rosa Álvarez, Raquel Correa, C.Nieves Hernández-León, Gloria Marquina, Nadia Hindi, Andrés Redond
Cancer Treatment Reviews.2021; 99: 102259.     CrossRef
Myxofibrosarcoma harboring an MLH1 pathogenic germline variant associated with Muir-Torre syndrome: a case report
Makoto Nakagawa, Eisuke Kobayashi, Masayoshi Yamada, Tomoko Watanabe, Makoto Hirata, Noriko Tanabe, Mineko Ushiama, Hiromi Sakamoto, Chiaki Sato, Taisuke Mori, Akihiko Yoshida, Teruhiko Yoshida, Kokichi Sugano, Akira Kawai
Hereditary Cancer in Clinical Practice.2021;[Epub]     CrossRef
A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model
Tasuku Kiyuna, Yasunori Tome, Takashi Murakami, Kentaro Miyake, Kentaro Igarashi, Kei Kawaguchi, Hiromichi Oshiro, Takashi Higuchi, Masuyo Miyake, Norihiko Sugisawa, Zhiying Zhang, Sahar Razmjooei, Sintawat Wangsiricharoen, Bartosz Chmielowski, Scott D. N
Biochemical and Biophysical Research Communications.2018; 505(3): 733.     CrossRef